Treatment adherence/self-care behaviour in heart failure patients Circulatory System Heart failure
Conditions
Interventions
The nurse from the heart failure clinic will refer eligible patients to the research nurse. After giving their informed consent, the patients will fill out the baseline questionnaire and will be rando
Sponsors
Montreal Heart Institute (Institut de cardiologie de Montréal) (Canada)
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Aged 18 years or more, either sex 2. Diagnosis of heart failure 3. French language 4. Physical and cognitive ability to answer a written questionnaire and to communicate by telephone 5. Physical and cognitive ability to read and sign a consent form 6. Problems with at least one self-care behaviour for HF patients (exercise, low-salt diet, fluid restriction, daily weight or medication) as evaluated by a clinic nurse
Exclusion criteria
Exclusion criteria: 1. Hospitalised at the time of enrolment 2. Final discharge from the heart failure clinic (i.e. no more follow-up)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Self-care frequency and self-care management will be measured at baseline and one month following randomisation using the following measures: 1. The Self-Care of Heart Failure Index (SCHFI) Sections A and B. Section A is an 11-item questionnaire which measures the frequency of self-care behaviours including exercise, low-salt diet, fluid restriction, daily weight or medication using a 4-point Likert scale. A higher score indicates an optimal frequency of self-care behaviours. Section B, a 6-item questionnaire, is divided in three subsections. Section 1 contains one item using a 4-point Likert scale, section 2 contains three items using a 4-point Likert scale and section 3 contains two items using a 5-point Likert scale. Summing these answers provides a total score; higher scores indicate optimal management of self-care. 2. The Therapeutic Self-Care Tool (TSCT) measures the patients' ability to initiate and perform activities aimed at maintaining health, managing health problems, and restoring functioning, using a 12-item questionnaire and a 5-point Likert scale. A higher score indicates better self-care capacities. | — |
Secondary
| Measure | Time frame |
|---|---|
| The following variables will be measured at baseline and one month following randomisation: 1. The frequency of specific heart failure self-care behaviours will be measured in the treatment group only, using the Self-Care of Heart Failure Index. To assess this variable, we will use only the item(s) referring to the behaviour on which the intervention is focused. For example, if a patient is focusing on a low salt diet, only the item assessing this self-care behaviour will be retained. 2. Confidence to change will be measured using the Questionnaire of Health Belief. The first subscale, an 8-item questionnaire, uses a 5-point Likert scale to measure the perception of barriers to change. A higher score indicates a higher level of confidence, or fewer barriers. 3. Confidence specific to heart failure patients will be measured using the Self-Care of Heart Failure Index Section C. This is a 6-item questionnaire which uses a 4-point Likert scale to measure confidence in respecting self-care. A higher score indicates a higher level of confidence. 4. Conviction to change will be measured using the Questionnaire of Health Belief second subscale. This is a 4-item questionnaire which uses a 5-point Likert scale to measure the perception of benefits to change. A higher score indicates fewer benefits. 5. Acceptability of the intervention will be measured using the Treatment Acceptability and Preference Questionnaire. This is a 4-item questionnaire which uses a 5-point Likert scale to measure the patients' opinion of the acceptability of a treatment. A higher score indicates greater acceptability of the treatment. An overall satisfaction question is also asked. 6. Feasibility of the intervention will be assessed by documenting the number of patients who: 6.1 Are eligible 6.2. Agree to participate in the study 6.3. Remain in the study one month after randomisation 7. Progression through the stages of change will be assessed using the evaluation made by the research nurse followi | — |
Countries
Canada
Outcome results
None listed